Wessex Cardiac Centre, Southampton University Hospitals, Southampton, UK.
Europace. 2009 Nov;11 Suppl 5:v22-8. doi: 10.1093/europace/eup306.
Although cardiac resynchronization therapy (CRT) has demonstrated to be an effective treatment for heart failure patients, up to 30-40% of the patients do not show a favourable response. Implantation of the left ventricular (LV) pacing lead is one of the determinants of CRT response. This procedure includes several challenging technical issues and strongly depends on the highly variable anatomy of the coronary sinus and tributaries. In addition, the final position of the LV pacing lead may target the latest activated areas of the left ventricle in order to obtain effective resynchronization. Furthermore, the presence of transmural myocardial scar at the region targeted by the LV lead may also determine the response to CRT. This review discusses all the issues related to LV lead implantation and the role of multimodality imaging to anticipate the implantation strategy. Finally, alternative LV pacing sites and their effect on clinical outcome and LV performance will be discussed.
尽管心脏再同步治疗(CRT)已被证明对心力衰竭患者是一种有效的治疗方法,但仍有高达 30-40%的患者对此治疗反应不佳。左心室(LV)起搏导线的植入是 CRT 反应的决定因素之一。此过程包括多个具有挑战性的技术问题,并且强烈依赖于冠状动脉窦和分支的高度可变解剖结构。此外,LV 起搏导线的最终位置可能针对左心室的最新激活区域,以获得有效的再同步。此外,LV 起搏导线上靶向区域的透壁心肌瘢痕的存在也可能决定 CRT 的反应。本综述讨论了与 LV 导线植入相关的所有问题,以及多模态成像在预测植入策略中的作用。最后,将讨论替代的 LV 起搏部位及其对临床结果和 LV 功能的影响。